**Endocrine Agents: Estrogenic Agents**

| Criteria 1 | NP Criteria without QL                                                        |
| ---------- | ----------------------------------------------------------------------------- |
| Criteria 2 | Climara (NP, QL), Menostar (NP, QL), Minivelle (NP, QL), Vivelle-Dot (NP, QL) |

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Endocrine Agents: Estrogenic Agents</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Angeliq, Divigel, Duavee, Elestrin, Estrogel, Estradiol 10 mcg Vag tab, Estradiol/Norethindrone Acetate, Estrogel, Evamist, Femring, Prefest</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code(s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>ANGELIQ</td>
<td>059061</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ANGELIQ</td>
<td>069389</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>DIVIGEL</td>
<td>031004</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>DIVIGEL</td>
<td>060493</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>DIVIGEL</td>
<td>062784</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>DIVIGEL</td>
<td>079420</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>DIVIGEL</td>
<td>080597</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>DUAVEE</td>
<td>071889</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ELESTRIN</td>
<td>062699</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ESTROGEL</td>
<td>054628</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ESTRADIOL 10 mcg VAG TAB</td>
<td>078477</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ESTRADIOL 10 mcg VAG TAB</td>
<td>078816</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ESTRADIOL 10 mcg VAG TAB</td>
<td>065966</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ESTRADIOL/NORETHINDRONE ACETATE</td>
<td>040888</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ESTRADIOL/NORETHINDRONE ACETATE</td>
<td>062587</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>EVAMIST</td>
<td>062960</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FEMRING</td>
<td>052093</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FEMRING</td>
<td>052094</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>PREFEST</td>
<td>044113</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number</strong></th>
<th><strong>Question ID</strong></th>
<th><strong>Default Next Question ID</strong></th>
<th><strong>Question Type</strong></th>
<th><strong>Question Text</strong></th>
<th><strong>Choice Text</strong></th>
<th><strong>Next Question ID</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>5999</td>
<td></td>
<td>Select </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?  </p>
<p>  </p></td>
<td>New Start (initial authorization request)</td>
<td>6000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1234</td>
</tr>
<tr class="odd">
<td>2</td>
<td>6000</td>
<td></td>
<td>Select </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?  </td>
<td>Y </td>
<td>6001</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>3</td>
<td>6001</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">30 days</span> with at least <span class="underline">two preferred</span> drugs? </p>
<p>Please note: Requests for non-preferred drugs must have an inadequate clinical response with preferred drugs with the same delivery method.</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y </td>
<td>6003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>6002 </td>
</tr>
<tr class="odd">
<td>4</td>
<td>6002</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use. </p></td>
<td>Y   </td>
<td>6003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N   </td>
<td>1236</td>
</tr>
<tr class="odd">
<td>5</td>
<td>6003</td>
<td></td>
<td>Select</td>
<td>Is the request for Brand Divigel or generic estradiol gel (generic for Divigel)?</td>
<td>Y</td>
<td>6004</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>6006</td>
</tr>
<tr class="odd">
<td>6</td>
<td>6004</td>
<td></td>
<td>Select</td>
<td>Which product is being requested?</td>
<td>Brand Divigel</td>
<td>6006</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Brand Elestrin</td>
<td>6006</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Brand Estrogel</td>
<td>6006</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Generic estradiol gel (generic for Divigel)</td>
<td>6005</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Other</td>
<td>1235</td>
</tr>
<tr class="even">
<td>7</td>
<td>6005</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the brand medication been attempted and failed or is the brand medication contraindicated?  </p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>6006</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>8</td>
<td>6006</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred extended release formulation</p>
<p>3) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>6007</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td>9</td>
<td>6007</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation, inadequate clinical response with a product’s immediate release formulation, or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>10</td>
<td>1234</td>
<td></td>
<td>Select and Free Text  </td>
<td>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring?</td>
<td> Y    </td>
<td>END (Pending Manual Review) </td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td> N    </td>
<td>1235 </td>
</tr>
<tr class="even">
<td>11</td>
<td>1235</td>
<td></td>
<td>Free Text</td>
<td>Please provide the rationale for the medication being requested. </td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
<tr class="odd">
<td>12</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: 365 Days

| **Last Approved ** | 5/16/2023 |
| ------------------ | --------- |
| **Other**          |           |

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Endocrine Agents: Estrogenic Agents</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Climara, Menostar, Minivelle, Vivelle-Dot</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td> GCNSeqNo</td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code(s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>CLIMARA</td>
<td>023471</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>CLIMARA</td>
<td>023472</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>CLIMARA</td>
<td>032174</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>CLIMARA</td>
<td>040366</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>CLIMARA</td>
<td>052830</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>CLIMARA</td>
<td>052831</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MENOSTAR</td>
<td>054714</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MINIVELLE</td>
<td>003202</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MINIVELLE</td>
<td>003203</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MINIVELLE</td>
<td>016767</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MINIVELLE</td>
<td>023270</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MINIVELLE</td>
<td>024555</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>VIVELLE-DOT</td>
<td>003202</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>VIVELLE-DOT</td>
<td>003203</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>VIVELLE-DOT</td>
<td>016767</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>VIVELLE-DOT</td>
<td>023270</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number</strong></th>
<th><strong>Question ID</strong></th>
<th><strong>Default Next Question ID</strong></th>
<th><strong>Question Type</strong></th>
<th><strong>Question Text</strong></th>
<th><strong>Choice Text</strong></th>
<th><strong>Next Question ID</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>5999</td>
<td></td>
<td>Select </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?  </p>
<p>  </p></td>
<td>New Start (initial authorization request)</td>
<td>6000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1234</td>
</tr>
<tr class="odd">
<td>2</td>
<td>6000</td>
<td></td>
<td>Select </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?  </td>
<td>Y </td>
<td>6001</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>3</td>
<td>6001</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">30 days</span> with at least <span class="underline">two preferred</span> drugs? </p>
<p>Please note: Requests for non-preferred drugs must have an inadequate clinical response with preferred drugs with the same delivery method.</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y </td>
<td>6003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>6002 </td>
</tr>
<tr class="odd">
<td>4</td>
<td>6002</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use. </p></td>
<td>Y   </td>
<td>6003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N   </td>
<td>1236</td>
</tr>
<tr class="odd">
<td>5</td>
<td>6003</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred extended release formulation</p>
<p>3) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>6004</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td>6</td>
<td>6004</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation, inadequate clinical response with a product’s immediate release formulation, or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>7</td>
<td>1234</td>
<td></td>
<td>Select and Free Text  </td>
<td>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring?</td>
<td> Y    </td>
<td>END (Pending Manual Review) </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td> N    </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>8</td>
<td>1235</td>
<td></td>
<td>Free Text</td>
<td>Please provide the rationale for the medication being requested. </td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
<tr class="even">
<td>9</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: 365 Days

| **Last Approved ** | 5/16/2023 |
| ------------------ | --------- |
| **Other**          |           |
